Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
101M
-
Number of holders
-
234
-
Total 13F shares, excl. options
-
101M
-
Shares change
-
+19.9M
-
Total reported value, excl. options
-
$1.98B
-
Value change
-
+$387M
-
Put/Call ratio
-
0.73
-
Number of buys
-
136
-
Number of sells
-
-77
-
Price
-
$19.53
Significant Holders of Beam Therapeutics Inc. - COMMON STOCK (BEAM) as of Q1 2025
274 filings reported holding BEAM - Beam Therapeutics Inc. - COMMON STOCK as of Q1 2025.
Beam Therapeutics Inc. - COMMON STOCK (BEAM) has 234 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 101M shares
.
Largest 10 shareholders include FARALLON CAPITAL MANAGEMENT LLC (9.93M shares), VANGUARD GROUP INC (8.87M shares), ARK Investment Management LLC (8.48M shares), BlackRock, Inc. (8.1M shares), FMR LLC (7.92M shares), ARCH Venture Management, LLC (4.54M shares), Nikko Asset Management Americas, Inc. (4.27M shares), Sumitomo Mitsui Trust Group, Inc. (4.27M shares), STATE STREET CORP (3.44M shares), and PRICE T ROWE ASSOCIATES INC /MD/ (3.03M shares).
This table shows the top 234 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.